CCT2 and gastric cancer: In gastric cancer, Tspan31 was found to be upregulated in tumor tissues, and silencing Tspan31 effectively inhibited migration and proliferation of GC cells by impairing the METTL1/CCT2 pathway (Ma et al., 2022).